We’re one of the first firms to deliver coverage of foreign growth companies tailored specifically to U.S. investors.

Research Reports

Our research reports are available to our clients. If you are an existing client and already have a username and password, please login. If you are an existing client and want to register for access to the site, please use the registration form below.

If you are a potential client and are interested in finding out how Chardan can help you, please contact Shai Gerson at 646-465-9008.

Datesort icon Company Title Sector Symbol Rating Analyst Document
October 15, 2014 Medical Transcription Billing, Corp. Partnership with Highlands Physicians, Inc. Reiterate Buy. Biotechnology & Pharmaceuticals MTBC Buy Ling Wang Log In or Register
October 15, 2014 Himax Technologies Weak Smartphone Demand could put Q4:14 Consensus at Risk; Reiterate Sell Technology HIMX Sell Jay Srivatsa Log In or Register
October 15, 2014 Chardan Global Insights - Oct 15 2014 HIMX Chardan Capital Markets Research Log In or Register
October 14, 2014 Globalstar Inc. Comments to FCC on TLPS submitted. Reiterate Buy and $6 Price Target. Agriculture Technology GSAT Buy JAMES McILREE, CFA Log In or Register
October 14, 2014 Chardan Global Insights - Oct 14 2014 GSAT NEA.AX Chardan Capital Markets Research Log In or Register
October 13, 2014 Chardan Global Insights - Oct 13 2014 IPM Chardan Capital Markets Research Log In or Register
October 13, 2014 Nearmap Ltd. US Expansion Plans: $30-$50M in revenue by 2017 Agriculture Technology NEA.AX Buy JAMES McILREE, CFA Log In or Register
October 10, 2014 Profire Energy Inc. Reiterate Buy and $5.80 Target. Top Pick in Energy Space. Telecom Services PFIE Buy JAMES McILREE, CFA Log In or Register
October 10, 2014 Chardan Global Insights - Oct 10 2014 NNVC PFIE Chardan Capital Markets Research Log In or Register
October 9, 2014 NanoViricides Inc. Management Update. Reiterate Buy. Biotechnology & Pharmaceuticals NNVC Buy Ling Wang Log In or Register

Coverage Universe

April 1, 2014

To learn more about our Research Group, please contact Jay Srivatsa at 646-465-9065